HTB news: latest research from CROI 2025, international US aid

LATEST NEWS

A focus on options after viral failure on CAB/RPV/LA at CROI 2025 and a recent journal scan.

Detailed report and linked coverage this week in the Lancet.

Controversial Spanish study using reduced Biktarvy dosing but with results that support further research in countries threatened with cuts to PEPFAR funding.

An introduction to this year’s conference and links to >12 early reports.

ALL REPORTS

All back issues

Please subscribe to receive a free email every 3-4 weeks of the latest news.

Reports will also be posted to social media at the same time.

Twitter (x)        Facebook        Instagram